Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy

Nimisha Sulejmani, Syed-Mohammed Jafri

Open source

DOI
10.2147/hmer.s130103
Published
2018-05
Container
Hepatic Medicine: Evidence and Research
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/hmer.s130103,
  title = {Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy},
  author = {Nimisha Sulejmani and Syed-Mohammed Jafri},
  year = {2018},
  journal = {Hepatic Medicine: Evidence and Research},
  doi = {10.2147/hmer.s130103},
  url = {https://doi.org/10.2147/hmer.s130103}
}

RIS

TY  - JOUR
TI  - Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy
AU  - Nimisha Sulejmani
AU  - Syed-Mohammed Jafri
PY  - 2018
JO  - Hepatic Medicine: Evidence and Research
DO  - 10.2147/hmer.s130103
UR  - https://doi.org/10.2147/hmer.s130103
ER  - 

APA

Sulejmani, N., & Jafri, S. (2018). Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy. Hepatic Medicine: Evidence and Research. https://doi.org/10.2147/hmer.s130103

Source records